Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
|Articles|February 11, 2022
Daily OTC Pearl: Joint Complex
Author(s)Saro Arakelians, PharmD
Joint Complex supports joint function and lubrication, as well as tissue hydration.
Advertisement
OTC/Lifestyle Pearl of the Day: Joint Complex
Indication: Supports overall joint health, mobility, and comfort.
Insight:
- Joint Complex supports joint function and comfort, as well as tissue hydration and joint lubrication.
- Directions: As a dietary supplement, take 3 caplets in the morning with food.
- Cautions: This product is only intended for healthy adults, 18 years of age or older.
- Keep out of reach of children
- Do not use if pregnant or nursing.
- Discontinue use and consult a health care professional if you experience any adverse reaction to this product.
- Do not use if safety seal is broken or missing.
- Storage: Store in a cool, dry place.
Source:
Advertisement
Related to this article
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
This article discusses a recent publication examining pharmacy access across Minnesota and explores the complex factors contributing to threatened community health access across the US.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
New Bladder Cancer Regimens Reshape Treatment Across Disease Stages
5